公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study | Huang C.-Y.; Tang Y.-H.; YING-CHENG CHIANG ; Wang K.-L.; Fu H.-C.; Ke Y.-M.; Lau H.-Y.; Hsu K.-F.; Wu C.-H.; WEN-FANG CHENG | Gynecologic Oncology | 29 | 26 | |
2001 | Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen | Hung C.-F.; WEN-FANG CHENG ; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. | Journal of Immunology | 131 | 114 | |
2014 | Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study | Hsu K.-F.; Chou H.-H.; Huang C.-Y.; Fu H.-C.; Chiang A.-J.; Tsai H.-W.; Chen J.-R.; WEN-FANG CHENG ; Ke Y.-M.; Chang C.-C.; Chen T.-H.; Lin S.-H.; Ho C.-M. | Gynecologic Oncology | 15 | 15 | |
2012 | Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: A retrospective observational study of Taiwanese Gynecologic Oncology Group | YU-LI CHEN ; Wang K.-L.; Chen M.-Y.; Yu M.-H.; Wu C.-H.; Ke Y.-M.; Chen Y.-J.; Chang Y.-Y.; Hsu K.-F.; Yen M.-S. | Journal of Gynecologic Oncology | 19 | 17 | |
2018 | Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: A Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study | Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG ; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S. | Journal of Gynecologic Oncology | 7 | 6 | |
2001 | Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. | Journal of Clinical Investigation | 250 | 0 |